Get started
Author

Jae Young Hur

Observed names: J Y Hur, J.Y. Hur, Jaeyoung Hur
Observed institutions: Seoul National University, Konkuk University, Asan Medical Center, Kyung Hee University, University of Ulsan, Konkuk University Medical Center
ORCID: 0000-0001-6105-9899
Observed ORCID: 0000-0001-6105-9899
OpenAlex ID: A5001134907
Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA
2018 · Jong Sik Lee, Jae Young Hur, et al. · BMC Cancer · 83
PDF
Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients
2018 · Jae Young Hur, Hee Joung Kim, et al. · Molecular Cancer · 82
PDF
Characteristics and Clinical Application of Extracellular Vesicle-Derived DNA
2021 · Jae Young Hur, Kye Young Lee · Cancers · 51
PDF
Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid from treatment-naive non-small cell lung cancer patients
2019 · Jae Young Hur, Jong Sik Lee, et al. · Translational Lung Cancer Research · 45
Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma
2020 · In Ae Kim, Jae Young Hur, et al. · Annals of Surgical Oncology · 36
PDF
Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma
2018 · In-Jae Oh, Jae Young Hur, et al. · Clinical Lung Cancer · 32
Genomic profiling of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid of patients with lung adenocarcinoma
2021 · Seung Eun Lee, Ha Young Park, et al. · Translational Lung Cancer Research · 30
PDF
Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid
2017 · Sojung Park, Jae Young Hur, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 29
Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC
2022 · In Ae Kim, Jae Young Hur, et al. · Cancers · 26
PDF
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
2020 · In Ae Kim, Jae Young Hur, et al. · Journal of Pathology and Translational Medicine · 26
PDF
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
2020 · Sunhee Chang, Jae Young Hur, et al. · Journal of Pathology and Translational Medicine · 23
PDF
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification
2019 · Jae Young Hur, Hyeong Ryul Kim, et al. · Cellular Oncology · 22
Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort study
2020 · Yoon Ho Ko, Seung Joon Kim, et al. · The Korean Journal of Internal Medicine · 13
PDF
Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile
2024 · Chinbayar Batochir, In Ae Kim, et al. · Cancers · 11
Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report
2017 · Cheol Kyu Park, Jae Young Hur, et al. · Journal of Korean Medical Science · 9
PDF
Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib
2021 · Ji An Hwang, Jae Young Hur, et al. · Translational Cancer Research · 8
PDF
A prospective phase 2 study of expeditious EGFR genotyping and immediate therapeutic initiation through extracellular vesicles (EV)-based bronchoalveolar lavage fluid (BALF) liquid biopsy in advanced NSCLC patients
2023 · In Ae Kim, Jae Young Hur, et al. · Translational Lung Cancer Research · 5
PDF
Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring EGFR Mutations
2021 · In Ae Kim, Jae Young Hur, et al. · Cancers · 5
PDF
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient
2017 · Jong Sik Lee, Jae Young Hur, et al. · Journal of Thoracic Oncology · 3
PDF
MA25.07 Genomic Profiling of Lung Adenocarcinoma by Targeted NGS Using Extracellular Vesicle-Derived DNA in Bronchoalveolar Lavage Fluid
2019 · S. Lee, K.Y. Lee, et al. · Journal of Thoracic Oncology · 1
PDF
P2.01-62 Extracellular Vesicle-Based Egfr Genotyping in Bronchoalveolar Lavage Fluid from Non-Small Cell Lung Cancer Patients
2018 · J.S. Lee, J.Y. Hur, et al. · Journal of Thoracic Oncology · 1
Bronchoalveolar lavage fluid cfDNA liquid biopsy-guided neoadjuvant lazertinib in resectable EGFR-mutant non-small cell lung cancer: a prospective phase II study
2026 · In Ae Kim, Heejoung Kim, et al. · Translational Lung Cancer Research
Bronchoalveolar lavage fluid EGFR genotyping during bronchoscopic biopsy: concordance with tissue and additional molecular diagnostic yield in lung cancer
2026 · Duk Ki Kim, Jae Young Hur, et al. · Translational Lung Cancer Research
Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study
2026 · Heejoung Kim, Jaeyoung Hur, et al. · Translational Lung Cancer Research
Low frequency of MLLT10 risk SNPs in Korean meningiomas: an exploratory analysis highlighting population-specific differences.
2026 · J Y Hur, Y H Shim, et al. · PubMed
Works count: 39
Citation count: 541
H-index: 13
I10-index: 14
Year
Topic
Type